Compare Main Street Capital Corporation (MAIN) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Main Street Capital Corporation vs TransMedics Group Inc — how do they compare? Main Street Capital Corporation trades at $59 (market cap $5.52B), while TransMedics Group Inc trades at $89.19 (market cap $3.10B). The key difference: Main Street Capital Corporation is the larger of the two by market cap, and Main Street Capital Corporation pays a 5.39% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| MAIN | TMDX | |
|---|---|---|
Market Cap | $5.52B | $3.10B |
Sector | Financials | Technology |
52-Week High | $67.54 | $150.42 |
52-Week Low | $49.63 | $61.99 |
Dividend Yield | 5.39% | — |
Enterprise Value | — | $3.49B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Main Street Capital Corporation
Main Street Capital Corp is an investment firm engaged in providing customized debt and equity financing to lower middle market companies and debt capital to middle market companies. The investment portfolio of the company is typically made to support management buyouts, recapitalizations, growth financings, refinancings and acquisitions of companies that operate in diverse industry sectors. The group invests in secured debt investments, equity investments, warrants and other securities of the lower middle market and middle market companies based in the US. Business is functioned through the U.S region and it derives the majority of the income from the source of fee, commission, and interest.
Read more on MAIN →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
